Abstract:Hypercatabolism plays a critical role in the pathogenesis of post-critical care debility in critical patients. Central nervous system may exerte a critical role in the regulation of hypercatabolism. However, little is known about the exact mechanisms of the central role. Here, we reported that actived hypothalamic AMP-activated protein kinase (AMPK)-induced autophagy modulated the expression of POMC to ameliorate hypercatabolism in septic rats. Firstly, rats were i.c.v. injected with the lentiviral vector containing shRNA against POMC. Two weeks after injections, rats were intraperitoneally injected with LPS or saline. Twenty-four hours later, blood, skeletal muscle and hypothalamus tissues were obtained. Hypercatabolism markers and neuropeptides expression were detected. Then, rats were injected with AICAR or saline into third ventricle and promptly intraperitoneally injected with LPS or saline. Twenty-four hours after infection, blood, skeletal muscle and hypothalamus tissues were obtained. Hypercatabolism, hypothalamic AMPK-induced autophagy markers and neuropeptides expression were also detected. Results showed that sepsis would decrease the level of hypothalamic autophagy accompany with the alterations of POMC expression and hypercatabolism. Knocking out hypothalamus POMC expression could significantly ameliorate hypercatabolism. Moreover, Central activation of AMPK-induced autophagy pathway via third ventricle injection of AICAR, an AMPK activator, could efficiently ameliorate hypercatabolism as well as attenuate the elevated POMC expression rather than other neuropeptides. Taken together, these results suggested that hypothalamic AMPK-autophagy pathway as a regulatory pathway for POMC expression was essential for hypercatabolism during sepsis. And hypothalamic AMPK-autophagy activation could attenuate the POMC expression to ameliorate hypercatabolism. Pharmaceuticals with the ability of activating hypothalamic AMPK-autophagy pathway may be a therapeutic potential for hypercatabolism in septic patients.

AMPK regulates immunometabolism in sepsis.

Targeting AMP-activated protein kinase in sepsis

Role Of Ampk Alpha In Skeletal Muscle Glycometabolism Regulation And Adaptation In Relation To Sepsis

PKM2-dependent Glycolysis Promotes NLRP3 and AIM2 Inflammasome Activation

The endotoxemia cardiac dysfunction is attenuated by AMPK/mTOR signaling pathway regulating autophagy.

Research progress on AMPK/mTOR signaling pathway involved in immunometabolic regulation in sepsis

Macrophage Alpha 1 Amp-Activated Protein Kinase (alpha 1ampk) Antagonizes Fatty Acid-Induced Inflammation Through Sirt1

Hypothalamic AMPK-induced Autophagy Ameliorates Hypercatabolism in Septic Rats by Regulating POMC Expression

Research Advances of Cationic Antimicrobial Peptides in the Immune Response in Sepsis

Abstract 15517: Deficiency of AMPK Exacerbates Lipopolysaccharide-Induced Cardiac Contractile Dysfunction: the Role of Autophagy

p38 MAPK and MKP-1 control the glycolytic program via the bifunctional glycolysis regulator PFKFB3 during sepsis

MKP-1 Modulates Mitochondrial Transcription Factors, Oxidative Phosphorylation, and Glycolysis

Inhibition of aerobic glycolysis alleviates sepsis‐induced acute kidney injury by promoting lactate/Sirtuin 3/AMPK‐regulated autophagy

cAMP metabolism controls caspase-11 inflammasome activation and pyroptosis in sepsis

AMPK Inhibition Blocks ROS-NFκB Signaling and Attenuates Endotoxemia-Induced Liver Injury.

Maackiain Protects Against Sepsis Via Activating AMPK/Nrf2/HO-1 Pathway

AMPK activation improves recovery from pneumonia-induced lung injury via reduction of er-stress and apoptosis in alveolar epithelial cells

A New Strategy for Targeting UCP2 to Modulate Glycolytic Reprogramming as a Treatment for Sepsis A New Strategy for Targeting UCP2

The regulation effect of AMPK in immune related diseases

SphK1 Regulates Proinflammatory Responses Associated with Endotoxin and Polymicrobial Sepsis

Protective effect of omega-3 polyunsaturated fatty acids on sepsis via the AMPK/mTOR pathway